SCHEMBL31455300

SCHEMBL31455300

Cc1cc2nc(-c3cccnc3N)n(-c3ccc(C4CN(CC5CCC(C(=O)O)CC5)C4)cc3)c2nc1-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 20/20 0.46
AKT2 P31751 10/20 0.46
AKT3 Q9Y243 7/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31455068 1.00 AKT1 (0.46) AKT1AKT2AKT3
SCHEMBL31455125 0.93 AKT1 (0.45) AKT1AKT2AKT3
SCHEMBL31455281 0.93 AKT1 (0.45) AKT1AKT2AKT3
SCHEMBL31455666 0.88 AKT1 (0.57) AKT1AKT2AKT3
SCHEMBL31455484 0.88 AKT1 (0.57) AKT1AKT2AKT3
SCHEMBL31454985 0.87 AKT1 (0.58) AKT1AKT2AKT3
SCHEMBL31454981 0.87 AKT1 (0.58) AKT1AKT2AKT3
SCHEMBL31455228 0.85 AKT1 (0.59) AKT1AKT2AKT3
SCHEMBL31455367 0.85 AKT1 (0.59) AKT1AKT2AKT3
SCHEMBL31455245 0.84 AKT1 (0.42) AKT1AKT2AKT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059577-A1 SUBSTITUTED AMINOPYRIDINE COMPOUNDS FOR USE AS AKT1 INHIBITORS ATAVISTIK BIO, INC. (US) 2025-03-20 WO disclosed